WilmerHale Advises BioCatch in $145 Million Series C Funding

WilmerHale Advises BioCatch in $145 Million Series C Funding

Client News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.
Critical industry insight and formidable strength across key practices.

On April 15, 2020, BioCatch, the global leader in behavioral biometrics, announced that it completed a $145 million Series C investment led by Bain Capital Tech Opportunities. The investment will accelerate BioCatch’s rapid growth, broaden its product offerings and further support its expanding client base into new verticals.

The WilmerHale team representing BioCatch was led by Stephanie Evans and David Haber, and included Michael Bevilacqua, William Caporizzo, Jay Holtmeier, Barry Hurewitz, Scott Kilgore, Chavi Keeney Nana, Evan Kirsch, Tyler Rostock, Chanda Brown and Alex Bernstein.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel